The Valley Desk

NCT04272203 · Interventional trial

A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers

Overall registry status Terminated

Phase 1

Conditions Acute Myeloid Leukemia (AML), Cancer, Non Small Cell Lung Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov